Importantly, adipocyte‐specific deletion of Mettl14 blocked HFD‐induced obesity, insulin resistance, glucose intolerance, and NAFLD, accompanied by increased β adrenergic signaling and lipolysis in WAT. This evidence concerns the gene METTL14 and metabolic dysfunction-associated steatotic liver disease.